Entrada Therapeutics, Inc. (TRDA)
12.58
+0.96
(+8.26%)
USD |
NASDAQ |
Mar 06, 16:00
12.81
+0.23
(+1.83%)
After-Hours: 20:00
Entrada Therapeutics Market Cap : 481.62M for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| EyePoint Plc | 1.308B |
| Repligen Corp. | 6.759B |
| Vertex Pharmaceuticals, Inc. | 116.01B |
| Kodiak Sciences, Inc. | 1.518B |
| Arcutis Biotherapeutics, Inc. | 2.977B |
Market Cap Related Metrics
| PS Ratio | 20.47 |
| Price to Book Value | 1.573 |
| Price | 12.58 |
| Earnings Yield | -27.59% |